Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens

Huib A. A. M. van Vliet(Leiden University Medical Center), Frans M. Helmerhorst(Leiden University Medical Center), M. Christella, Frits R. Rosendaal(Leiden University Medical Center), Marijke Frölich, Stella Thomassen(Maastricht University), Jan Rosing(Maastricht University), Carine J.M. Doggen(Rijnstate Hospital)
Human Reproduction
November 12, 2004
10.1093/humrep/deh612
Cited by 88

Related Papers

Incidence and mortality of venous thrombosis: a population‐based study
|Journal of Thrombosis and Haemostasis|2007|1.4k
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
|The Lancet|2011|1.3k
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
|The Lancet|1994|1.1k
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
|New England Journal of Medicine|1996|1.1k
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.
|PubMed|2001|803